2.55 (-%)
As of Dec 03, 2024
Source:
Hookipa Pharma Inc is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on our proprietary arenavirus platform that is designed to target and amplify T cell and immune responses to fight diseases.
Country | United States |
Headquarters | new york, new york |
Phone Number | 43 1 890 63 60 |
Industry | manufacturing |
CEO | Joern Aldag |
Website | www.hookipapharma.com |